Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia

Published:2021-02-24 Issue:3 Volume:5 Page:e543
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Della Starza Irene,Nunes Vittorio,Lovisa Federica,Silvestri Daniela,Cavalli Marzia,Garofalo Andrea,Campeggio Mimma,De Novi Lucia Anna,Soscia Roberta,Oggioni Carlotta,Mussolin Lara,Biondi Andrea,Guarini Anna,Valsecchi Maria Grazia,Conter Valentino,Biffi Alessandra,Basso Giuseppe,Foà Robin,Cazzaniga Giovanni

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference21 articles.

1. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.;Pui;Lancet Oncol,2015

2. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.;Conter;Blood,2010

3. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.;Schrappe;Blood,2011

4. Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch childhood oncology group.;Pieters;J Clin Oncol,2016

5. Improving stratification for children with late bone marrow B-cell acute lymphoblastic leukemia relapses with refined response classification and integration of genetics.;Eckert;J Clin Oncol,2019

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Backtracking childhood leukaemia to birth: A battle of addition;British Journal of Haematology;2024-09-05

2. Monitoring measurable residual disease in paediatric acute lymphoblastic leukaemia using immunoglobulin gene clonality based on next-generation sequencing;Cancer Cell International;2024-06-25

3. Monitoring Measurable Residual Disease in ALL and AML;The EBMT Handbook;2024

4. Novel precision medicine approaches and treatment strategies in hematological malignancies;Journal of Internal Medicine;2023-08-07

5. Minimal residual disease in Philadelphia‐positive acute lymphoblastic leukemia: Maximizing the clinical yield of testing;American Journal of Hematology;2023-06-14